 |
|
Getting a Handlle on Managing Rare TumorsComment on "Treatment of Hepatic Epithelioid Hemangioendothelioma"
James C. Hebert, MD
Arch Surg. 2009;144(11):1039.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Few surgeons will ever encounter patients with EHE, a rare tumor. In this article, Cardinal and colleagues have summarized the current state of management for EHE and have shared their experience for treating patients with these unusual tumors. As they point out, there are no distinguishing characteristics for diagnosis, and these tumors can mimic a variety of other tumors. Careful pathologic analysis with appropriate tumor markers should be used to make the diagnosis, and appropriate imaging should be performed to evaluate for extrahepatic disease. Liver transplant is currently the most widely recommended therapy.
The present series describes a single institution's experience managing these tumors. Although the numbers are small, the observations presented are intriguing. Regional lymphovascular invasion did not seem to affect the outcome after transplant. Extrahepatic disease was associated with poorer outcomes, as might be expected. Transcatheter arterial chemoembolization was as effective as resection for . . . [Full Text of this Article]
AUTHOR INFORMATION
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Treatment of Hepatic Epithelioid Hemangioendothelioma: A Single-Institution Experience With 25 Cases
Jon Cardinal, Michael E. de Vera, James W. Marsh, Jennifer L. Steel, David A. Geller, Paulo Fontes, Michael Nalesnik, and T. Clark Gamblin
Arch Surg. 2009;144(11):1035-1039.
ABSTRACT
| FULL TEXT
|
